Physician Data Query

Last uploaded: January 31, 2024
Preferred Name

sufentanil citrate

Synonyms

N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide Citrate

Definitions

The citrate salt form of sufentanil, a synthetic congener of fentanyl and related to the phenylpieridines, with analgesic property. Sufentanil citrate binds to and activates the mu-opioid receptor, thereby producing analgesia, respiratory depression, miosis, reduced gastrointestinal motility, and euphoria. In addition, this agent has a more rapid onset of action and shorter duration of action compared to fentanyl. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47731" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47731" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000524060

altLabel

N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide Citrate

N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)-N-phenylpropionamide Citrate

Fentatienil

Propanamide, N-(4-(methoxymethyl)-1-(2-(thienyl)ethyl)-4-piperidinyl)-N-phenyl-, 2-hydroxy-1,2,3-propanetricarboxylate(1:1)

Sufenta

CAS Registry

60561-17-3

cui

C0162792

C0733851

DATE FIRST PUBLISHED

2006-12-01

definition

The citrate salt form of sufentanil, a synthetic congener of fentanyl and related to the phenylpieridines, with analgesic property. Sufentanil citrate binds to and activates the mu-opioid receptor, thereby producing analgesia, respiratory depression, miosis, reduced gastrointestinal motility, and euphoria. In addition, this agent has a more rapid onset of action and shorter duration of action compared to fentanyl. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47731" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47731" NCI Thesaurus)

LT

TRD

NCI ID

C47731

notation

CDR0000524060

ORIG STY

Drug/agent

prefLabel

sufentanil citrate

tui

T109

T121

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/NDFRT/N0000179348 NDFRT CUI
http://purl.bioontology.org/ontology/MESH/D017409 MESH CUI
http://purl.bioontology.org/ontology/MESH/D017409 MESH CUI
http://purl.bioontology.org/ontology/VANDF/4019269 VANDF CUI
http://purl.bioontology.org/ontology/SCTSPA/37527009 SCTSPA CUI
http://purl.bioontology.org/ontology/SNOMEDCT/37527009 SNOMEDCT CUI
http://purl.bioontology.org/ontology/RXNORM/58964 RXNORM CUI
http://purl.bioontology.org/ontology/NDDF/001570 NDDF CUI
http://purl.bioontology.org/ontology/MSHFRE/D017409 MSHFRE CUI
http://purl.bioontology.org/ontology/NDFRT/N0000147468 NDFRT CUI
http://purl.bioontology.org/ontology/SNMI/C-60701 SNMI CUI
http://purl.obolibrary.org/obo/CHEBI_9317 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_9317 BERO LOOM
http://purl.bioontology.org/ontology/VANDF/4019269 VANDF LOOM
http://stirdf.jst.go.jp/id/200907057531013524 IOBC LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/37527009 SNOMEDCT LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0162792 OCHV LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47731 NCIT LOOM
http://purl.bioontology.org/ontology/RXNORM/58964 RXNORM LOOM
http://purl.bioontology.org/ontology/NDDF/001570 NDDF LOOM
http://id.nlm.nih.gov/mesh/D017409 MDM LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#17987 OCHV LOOM
http://purl.obolibrary.org/obo/NCIT_C47731 BERO LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000147468 NDFRT LOOM
http://purl.jp/bio/4/id/200906032077220459 IOBC LOOM
http://purl.bioontology.org/ontology/SNMI/C-60701 SNMI LOOM